913653-14-2

Upstream product

• 149428-98-8 (5-chloro-2-((phenylmethyl)oxy)phenyl)acetic acid 
• 100-39-0 benzyl bromide 
• 913650-22-3 ethyl 2-((5-chloro-2-[(phenylmethyl)oxy]phenyl)methyl)-1,3-thiazole-4-carboxylate 
• 913650-10-9 2-(5-chloro-2-[(phenylmethyl)oxy]phenyl)ethanethioamide 
• 913649-93-1 ethyl (5-chloro-2-((phenylmethyl)oxy)phenyl)acetate 
• 1450-74-4 5-chloro-2-hydroxyacetophenone 
• 913651-21-5 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazole-4-carboxylic acid 
• 913652-13-8 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazole-4-carboxamide 
• 913653-12-0 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-N-[(1E)-(dimethylamino)methylidene]-1,3-thiazole-4-carboxamide 

Relevant academic research and scientific papers

OXAZOLE AND THIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PGE2 MEDIATED DISORDERS

Compounds of formula (I) or a pharmaceutiically acceptable derivative thereof: wherein X, Z, Y', Y'', R1 ,R2a, R2b, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.